Papers
2
Total Citations
9
H-Index
2
About
Dr. Chongyuan Sun is a surgical oncologist whose research focuses on improving outcomes for patients with hepatopancreatobiliary malignancies, particularly ampullary carcinoma and bile duct injuries. His major contributions include the development of novel prognostic scoring systems that integrate preoperative biomarkers—such as the total bilirubin-albumin ratio and fibrinogen-albumin ratio—to better stratify risk in ampullary adenocarcinoma patients. Dr. Sun also pioneered the concept of “textbook outcomes” for ampullary carcinoma patients undergoing pancreaticoduodenectomy, establishing composite quality metrics that capture ideal postoperative recovery. His work on postcholecystectomy bile duct injury has shed light on the persistent burden of this iatrogenic complication, emphasizing its impact on quality of life and healthcare costs. With his most-cited paper accumulating 6 citations and his innovative scoring system gaining 3 citations, Dr. Sun’s research is steadily influencing clinical decision-making in pancreatic surgery. His achievements demonstrate a commitment to translating laboratory findings into practical, patient-centered tools that enhance surgical safety and prognostic accuracy.
Research Focus
Key Achievements
Top Papers
- 1
- 2